Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

The terms of the IPO were not disclosed in the filing. Strong equity markets, falling interest rates and hopes of a ...

Trusted by U.S. Physicians and Pharmacies and Available Nationwide. Take Control of Your Weight Loss Journey: How Does GLP-1 ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

A new request by Ozempic manufacturer Novo Nordisk could limit the availability of a type of GLP-1—semaglutides—to local ...

The firm said it struck a three-year licensing deal with a top pharmaceutical company that will use the data to advance GLP-1 receptor agonist research.

As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.

Industry leaders share their thoughts and concerns about the health care landscape and how it will affect their 2025.

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...